3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Fallopian Tube Neoplasms
1
Interventions
X-Rays
2
Platinum
2
Magnetic Resonance Spectroscopy
2
Hyperthermic Intraperitoneal Chemotherapy
2
Drug Therapy
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
Aspirin
2
1,2-diaminocyclohexaneplatinum II citrate
2
talazoparib
1
sodium thiosulfate
1
propranolol CR
1
pembrolizumab
1
olaparib
1
epacadostat
1
adavosertib
1
Taxes
1
Specimen Handling
1
Propranolol
1
Paclitaxel
1
Ketorolac Tromethamine
1
Ketorolac
1
Fluoresceins
1
Fluorescein
1
Doxorubicin
1
Carboplatin
1
Auranofin
1
4-(3-fluoropropyl)glutamic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Fallopian Tube Neoplasms
×
talazoparib
×
Clear all
NCT02316834
2022-02-24
POSITION
M.D. Anderson Cancer Center
Phase EARLY_PHASE1
Completed
4 enrolled